[Effect of preterm birth on maternal mental illness]
Souhrn: Souhrnný článek o předčasném porodu jako nezávislém rizikovém faktoru rozvoje duševního onemocnění matky. Metodika: Přehled publikované literatury k danému tématu použitím databáze PubMed. Výsledky: Perinatální duševní zdraví ovlivňuje zásadně život matky a vývoj dítěte, a proto jde v širší souvislosti o celospolečenskou problematiku. Samostatnou vysoce rizikovou skupinou, kde lze očekávat deterioraci psychického stavu, jsou ženy, kterým se narodí nezralý novorozenec <32+0 týden těhotenství Very Low Birth Weight (VLBW) a <28+0 týden těhotenství Extremely Low Birth Weight (ELBW). Závěr: Mezi nejčastější duševní poruchy tohoto období patří poporodní deprese (PPD) a úzkostná porucha (AD). Cílem je shrnout současné poznatky o vzájemném působení předčasného porodu a rozvoje psychických poruch a zdůraznit návaznost perinatální a duševní péče.
Summary: Comprehensive article on preterm birth as an independent risk factor for the development of maternal mental illness. Methodology: Review of published literature on the topic using the PubMed database. Results: Perinatal mental health significantly affects the lives of mothers and the development of children, making it a broader societal issue. A distinct high-risk group, where deterioration of mental health can be expected, consists of women giving birth to Very Low Birth Weight <32+0 weeks gestation and Extremely Low Birth Weight <28+0 weeks gestation premature infants. Conclusion: Among the most common mental disorders during this period are postpartum depression (PPD) and anxiety disorder (AD). The aim is to summarize current knowledge on the interaction between preterm birth and the development of mental disorders and emphasize the connection between perinatal and mental health care.
INTRODUCTION: Maternal sepsis is a leading cause of maternal and neonatal mortality. Despite the availability of management protocols, there is disparity in case fatality rates for pregnancy-related sepsis compared to other maternity-related complications. The main aim of this systematic review was to assess concordance between international evidence-based guidelines for the prevention and management of childbirth-related bacterial infections. MATERIAL AND METHODS: The PRISMA statement was followed during the conduct and reporting of this review. PubMed was searched electronically from 2009 to November 2019 for clinical guidelines covering the topic of childbirth-related infections and specific searches for relevant guidelines on the websites of the top five international professional bodies most commonly identified by our searches. We did not apply any language restrictions. Guidelines were included if they provided any information about the prevention or management of childbirth-related bacterial infections irrespective of whether the guideline stated a recommendation or not. Two independent reviewers undertook study selection, decisions about inclusion of selected guidelines and data extraction. Extracted information was synthesized under the following topics: Asymptomatic bacteriuria; group B streptococcal infection (GBS); preterm premature rupture of membranes (P-PROM); intrauterine infection; procedures; maternal sepsis; miscellaneous. Concordance was defined as absence of contradictory information between the different guidelines with regards to a specific topic, subtopic or recommendation. Quality of included guidelines was assessed against the AGREE II guideline reporting domains. RESULTS: A total of 43 guidelines were selected of which 11 were excluded leaving 32 guidelines that fulfilled our inclusion criteria. None of the guidelines fulfilled all the quality assessment domains and 11 (34%) of the guidelines satisfied 1-2 of domains only. Two guidelines covered the topic of asymptomatic bacteriuria, nine for GBS, five for P-PROM and three covered each of intra-amniotic infections maternal sepsis, obstetric procedures and interventions topics. The remaining guidelines covered miscellaneous topics. CONCLUSIONS: There was concordance between guidelines with regards to several aspects in the prophylaxis and treatment of bacteriological infections in pregnancy. Nevertheless, there were several areas of discordance, some of which reached the extent of contradictory information as in the case of antenatal screening for GBS.
- MeSH
- antibiotická profylaxe MeSH
- bakteriurie * komplikace MeSH
- infekční komplikace v těhotenství * diagnóza prevence a kontrola MeSH
- lidé MeSH
- novorozenec MeSH
- předčasný odtok plodové vody * mikrobiologie MeSH
- Streptococcus agalactiae MeSH
- streptokokové infekce * diagnóza prevence a kontrola MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
- MeSH
- lidé MeSH
- těhotenství * MeSH
- vakcinace * škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- těhotenství * MeSH
- ženské pohlaví MeSH
- Publikační typ
- přehledy MeSH
- Publikační typ
- abstrakt z konference MeSH
Kolonizace vaginy a rekta těhotných bakterií Streptococcus agalactiae (GBS) představuje riziko infekce matky, plodu nebo novorozence s potenciálně závažným průběhem a komplikacemi. V České republice je zaveden celoplošný screening na tuto bakterii u všech těhotných žen. Toto sdělení pojednává o prevalenci a citlivosti na antibiotika GBS u gravidních žen. Hodnotili jsme prevalenci kolonizace z let 2013 až 2020. Dále od poloviny roku 2019 začalo testování antibiotické citlivosti u všech GBS pozitivních kultur. Průměrná prevalence GBS vyšla 19,77 %. Rezistence na penicilin (ampicilin) odpovídá 0,65 %, na klindamycin 15,52 %, na erytromycin 20,45 % a na vankomycin 0 %.
Rectovaginal colonization with Group B Streptococcus (GBS) of pregnant women can lead to serious infection of woman, fetus or newborn and end up fataly. In Czech Republic every pregnant woman is screened for GBS colonization. This article aims to determine prevalence and antibiotic resistance of this bacteria. Prevalence of colonization from 2013 to 2020 was studied. Since 2019 each GBS specimen was tested to antibiotic sensi- tivity. Mean prevalence turned out to be 19,77%. Resistence to penicillin (ampicilin) was 0,65%, clindamycin 15,52%, erythromycin 20,45% and vancomycin 0%.
Gestational diabetes mellitus (GDM) is a complication in pregnancy, but studies focused on the steroidome in patients with GDM are not available in the public domain. This article evaluates the steroidome in GDM+ and GDM- women and its changes from 24 weeks (± of gestation) to labor. The study included GDM+ (n = 44) and GDM- women (n = 33), in weeks 24-28, 30-36 of gestation and at labor and mixed umbilical blood after delivery. Steroidomic data (101 steroids quantified by GC-MS/MS) support the concept that the increasing diabetogenic effects with the approaching term are associated with mounting progesterone levels. The GDM+ group showed lower levels of testosterone (due to reduced AKR1C3 activity), estradiol (due to a shift from the HSD17B1 towards HSD17B2 activity), 7-oxygenated androgens (competing with cortisone for HSD11B1 and shifting the balance from diabetogenic cortisol towards the inactive cortisone), reduced activities of SRD5As, and CYP17A1 in the hydroxylase but higher CYP17A1 activity in the lyase step. With the approaching term, the authors found rising activities of CYP3A7, AKR1C1, CYP17A1 in its hydroxylase step, but a decline in its lyase step, rising conjugation of neuroinhibitory and pregnancy-stabilizing steroids and weakening AKR1D1 activity.
- MeSH
- 20-hydroxysteroid dehydrogenasy metabolismus MeSH
- chromatografie plynová MeSH
- cytochrom P-450 CYP3A metabolismus MeSH
- druhý trimestr těhotenství metabolismus MeSH
- gestační diabetes metabolismus MeSH
- lidé MeSH
- metabolomika metody MeSH
- oxidoreduktasy metabolismus MeSH
- steroid-17-alfa-hydroxylasa metabolismus MeSH
- steroidy analýza MeSH
- tandemová hmotnostní spektrometrie MeSH
- těhotenství MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Pregnancy complicated by CKD is currently not fully understood topic. Outcome of pregnancy in patients with CKD is related to impaired glomerular filtration rate and the degree of proteinuria. In our study we evaluated the association of serum creatinine level and proteinuria with both maternal and fetal outcomes in the cohort of 84 pregnant patients with CKD. In CKD group we confirmed negative correlation of highest serum creatinine level in pregnancy to fetal weight (p value < 0.001) and gestation period (p value < 0.001). Likewise, negative correlation of preconception serum creatinine to fetal weight (p value < 0.001) and gestation period (p value 0.002). Negative correlation of proteinuria to gestation period (p value < 0.001) and fetal weight (p value < 0.001) was also demonstrated. CKD is serious risk factor for pregnancy outcome. Proteinuria and serum creatinine level should be examined before pregnancy and regularly monitored during pregnancy. Higher serum creatinine levels and higher proteinuria predispose to shorter gestation period and lower birth weight of the neonate.
- MeSH
- chronická renální insuficience komplikace MeSH
- dospělí MeSH
- kohortové studie MeSH
- komplikace těhotenství * MeSH
- kreatinin krev MeSH
- lidé MeSH
- novorozenec MeSH
- proteinurie etiologie MeSH
- rizikové faktory MeSH
- těhotenství MeSH
- výsledek těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Opakované ztráty těhotenství představují velmi citlivý problém nejen pro daný pár, ale také všechny zdravotníky, kteří se péče o ženu účastní. V širším kontextu zahrnují nejen opakované potraty, ale také problematiku periviabilního předčasného porodu s následným úmrtím novorozence a nevysvětlitelné fetální úmrtí. Tato oblast medicíny vyžaduje interdisciplinární přístup. Obor reprodukční imunologie nejlépe odpovídá na otázky spojené s komplikacemi těhotenství. V současné době nemáme k dispozici doporučení, kdo má o ženy s opakovanými ztrátami těhotenství pečovat. V článku shrnuji aktuální poznatky a naše zkušenosti s managementem péče, včetně kazuistiky.
Recurrent pregnancy losses represent sensitive issue not only for the couple, but also for all healthcare professionals involved. In a broader context, they include not only recurrent miscarriages, but also the issue of periviable preterm birth with subsequent neonatal death and unexplained fetal death. This area requires an interdisciplinary approach. The field of reproductive immunology best answers questions related to pregnancy complications. However, there is currently no accurate recommendation as to who should care for such women. In this article I summarize the current state of knowledge about the issue, current experience with care management, including case studies.
- MeSH
- dospělí MeSH
- habituální potrat * etiologie terapie MeSH
- heparin nízkomolekulární aplikace a dávkování terapeutické užití MeSH
- imunomodulace * MeSH
- komplikace těhotenství MeSH
- lidé MeSH
- péče před početím MeSH
- progesteron aplikace a dávkování terapeutické užití MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
- přehledy MeSH